The newly passed Senate amendment requiring drug companies to disclose the prices of their products in direct-to-consumer advertising is raising a lot of questions.
The newly passed Senate amendment requiring drug companies to disclose the prices of their products in direct-to-consumer advertising is raising a lot of questions.